{{Rsnum
|rsid=1431005
|Gene=NKX2-2
|Chromosome=4
|position=187424214
|Orientation=minus
|GMAF=0.3792
|Gene_s=NKX2-2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 41.4 | 46.8 | 11.7
| HCB | 37.2 | 49.6 | 13.1
| JPT | 35.4 | 46.9 | 17.7
| YRI | 40.3 | 45.8 | 13.9
| ASW | 39.3 | 51.8 | 8.9
| CHB | 37.2 | 49.6 | 13.1
| CHD | 45.9 | 40.4 | 13.8
| GIH | 39.6 | 49.5 | 10.9
| LWK | 41.7 | 41.7 | 16.7
| MEX | 35.1 | 49.1 | 15.8
| MKK | 34.2 | 47.1 | 18.7
| TSI | 32.7 | 48.5 | 18.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20339536
|Trait=Response to statin therapy
|Title=Genome-wide association of lipid-lowering response to statins in combined study populations
|RiskAllele=A
|Pval=2E-7
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}